Pirolate
 | |
| Systematic (IUPAC) name | |
|---|---|
|
ethyl 7,8-dimethoxy-4-oxo-1,4-dihydropyrimido[4,5-b]quinoline-2-carboxylate | |
| Clinical data | |
| Legal status |
|
| Routes of administration | Oral |
| Identifiers | |
| CAS Number | 55149-05-8 |
| ATC code | None |
| PubChem | CID 5361200 |
| ChemSpider | 4514698 |
| UNII |
2LF7L6QD58  |
| KEGG | D05508 |
| Chemical data | |
| Formula | C16H15N3O5 |
| Molar mass | 329.31 g/mol |
| |
Pirolate (CP-32,387) is an antihistamine drug with a tricyclic chemical structure which was patented as an antiallergen.[1][2] It was never marketed and there are very few references to it in the literature.[1]
References
- 1 2 David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
- ↑ Temple, Davis L. (1980). Drugs affecting the respiratory system: based on a symposium sponsored by the Division of Medicinal Chemistry, at the 175th meeting of the American Chemical Society, Anaheim, California, March 13-16, 1978. New Hope, Pa: The Society. ISBN 0-8412-0536-1.
| ||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, January 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.